The global cell harvesting market is witnessing remarkable growth, fueled by advancements in healthcare, biotechnology, and the integration of AI for precision and scalability. The market size was valued at USD 5.94 billion in 2024, grew to USD 6.71 billion in 2025, and is projected to reach approximately USD 20.08 billion by 2034, expanding at a robust CAGR of 12.95% during 2025–2034.
This growth is driven by the rising demand for personalized treatments, increased research activities, and strategic partnerships among key companies. Here’s an in-depth look at the market trends, regional growth, and profiles of the top companies dominating the cell harvesting industry.
📈 Key Market Insights
-
Market Size (2024): USD 5.94 billion
-
Forecast (2034): USD 20.08 billion
-
CAGR (2025–2034): 12.95%
-
North America’s Market Share (2024): 43%
-
Fastest Growing Region: Asia Pacific (2025–2030)
-
Top Product Segment (2024): Devices & Instruments (61% share)
-
Emerging Segment: Consumables (Fastest growth expected)
-
Leading Cell Type (2024): Mammalian Cells (53% share)
🌎 Regional Growth Overview
North America: Market Leader
With advanced healthcare infrastructure and strong research funding, North America dominated the market with a 43% share in 2024.
Asia Pacific: Fastest Growing Region
Asia Pacific is poised to grow rapidly between 2025 and 2030, thanks to increasing investments in biotechnology and growing healthcare needs.
🏢 Top Cell Harvesting Companies
1️⃣ Thermo Fisher Scientific Inc.
About: A global leader in scientific solutions headquartered in Massachusetts, USA.
Products: Offers cell harvesting systems, bioprocessing tools, and consumables.
Market Cap: Approx. USD 200 billion.
2️⃣ Merck KGaA (MilliporeSigma)
About: German multinational known for life sciences and healthcare solutions.
Products: Cell culture systems, harvesting technologies, and reagents.
Market Cap: Approx. USD 100 billion.
3️⃣ GE HealthCare (Cytiva)
About: Cytiva, under GE HealthCare, focuses on biopharmaceutical technologies.
Products: Cell harvesting equipment and scalable bioprocessing systems.
Market Cap: Approx. USD 32 billion (GE HealthCare).
4️⃣ Sartorius AG
About: German company excelling in bioprocess solutions and lab technologies.
Products: Automated harvesting systems and bioreactor accessories.
Market Cap: Approx. USD 25 billion.
5️⃣ Eppendorf SE
About: Renowned German company for laboratory instruments and consumables.
Products: Cell culture solutions, centrifuges, and harvesting tools.
Market Cap: Private (Estimated revenue: USD 1.3 billion).
6️⃣ BD Biosciences
About: Division of Becton Dickinson, focusing on life sciences and diagnostics.
Products: Cell processing instruments, reagents, and harvesting solutions.
Market Cap: Approx. USD 70 billion (Becton Dickinson).
7️⃣ Terumo BCT, Inc.
About: A subsidiary of Terumo Corporation specializing in blood and cell technologies.
Products: Cell separators, harvesting systems, and blood processing devices.
Market Cap: Approx. USD 12 billion (Terumo Corporation).
8️⃣ Beckman Coulter Life Sciences (Danaher)
About: Innovators in flow cytometry and cell processing solutions.
Products: Harvesting instruments and automation systems.
Market Cap: Approx. USD 170 billion (Danaher).
9️⃣ Miltenyi Biotec GmbH
About: German biotech firm known for cell separation and immunology tools.
Products: MACSQuant cell harvesting systems and reagents.
Market Cap: Private (Estimated revenue: USD 400 million).
🔟 Fresenius Kabi (CompoFlex & LOVO Systems)
About: Leading global provider of medical devices and biopharma products.
Products: LOVO cell processing systems for harvesting and washing cells.
Market Cap: Approx. USD 30 billion (Fresenius SE).
1️⃣1️⃣ Corning Incorporated
About: Known for advanced materials and lab consumables.
Products: Cell culture vessels and harvesting consumables.
Market Cap: Approx. USD 30 billion.
1️⃣2️⃣ Lonza Group AG
About: Swiss company offering contract manufacturing and bioprocess solutions.
Products: Harvesting systems and end-to-end bioprocess services.
Market Cap: Approx. USD 35 billion.
1️⃣3️⃣ Repligen Corporation
About: Specializes in bioprocessing technologies and consumables.
Products: XCell ATF systems for continuous cell harvesting.
Market Cap: Approx. USD 6 billion.
1️⃣4️⃣ Asahi Kasei Medical Co., Ltd.
About: Division of Asahi Kasei focusing on bioprocessing technologies.
Products: Cell processing systems and consumables.
Market Cap: Approx. USD 15 billion (Asahi Kasei Corporation).
1️⃣5️⃣ Stemcell Technologies Inc.
About: Canadian company specializing in cell culture and isolation tools.
Products: Cell harvesting reagents and instruments.
Market Cap: Private (Estimated revenue: USD 500 million).
1️⃣6️⃣ PerkinElmer Inc. (Revvity)
About: Global leader in diagnostics and life sciences solutions.
Products: Automated cell harvesting systems and reagents.
Market Cap: Approx. USD 15 billion.
If you have any questions, please feel free to contact us at sales@towardshealthcare.com
❓ Frequently Asked Questions (FAQs)
1. What is the projected size of the cell harvesting market by 2034?
The market is projected to reach approximately USD 20.08 billion by 2034.
2. Which region is expected to grow the fastest in the cell harvesting market?
The Asia Pacific region is expected to experience the fastest growth between 2025 and 2030.
3. Who are the leading players in the cell harvesting market?
Key players include Thermo Fisher Scientific, Merck KGaA, GE HealthCare, Sartorius AG, and BD Biosciences among others.
4. Which product segment dominates the market currently?
The Devices & Instruments segment held a 61% share in 2024 and continues to dominate.
5. How is AI contributing to cell harvesting advancements?
AI helps improve production efficiency, reduce contamination risks, and ensure precision in harvesting processes.
Source : https://www.towardshealthcare.com/insights/cell-harvesting-market-sizing
Invest in Our Premium Strategic Solution: https://www.towardshealthcare.com/price/5840
About the Author
